Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Avanos Medical (AVNS) Profit After Tax (2016 - 2026)

Avanos Medical's Profit After Tax history spans 13 years, with the latest figure at -$1.3 million for Q4 2025.

  • On a quarterly basis, Profit After Tax rose 99.67% to -$1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$72.9 million, a 81.27% increase, with the full-year FY2025 number at -$72.9 million, up 81.13% from a year prior.
  • Profit After Tax hit -$1.3 million in Q4 2025 for Avanos Medical, up from -$1.4 million in the prior quarter.
  • Over the last five years, Profit After Tax for AVNS hit a ceiling of $38.7 million in Q4 2022 and a floor of -$397.0 million in Q4 2024.
  • Historically, Profit After Tax has averaged -$27.6 million across 5 years, with a median of -$1.3 million in 2025.
  • Biggest five-year swings in Profit After Tax: skyrocketed 1383.33% in 2021 and later crashed 1886.05% in 2025.
  • Tracing AVNS's Profit After Tax over 5 years: stood at -$25.7 million in 2021, then skyrocketed by 250.58% to $38.7 million in 2022, then tumbled by 205.68% to -$40.9 million in 2023, then crashed by 870.66% to -$397.0 million in 2024, then skyrocketed by 99.67% to -$1.3 million in 2025.
  • Business Quant data shows Profit After Tax for AVNS at -$1.3 million in Q4 2025, -$1.4 million in Q3 2025, and -$76.8 million in Q2 2025.